ImpaQ Ecosystem•Clarivate, Scopus & CORE Data
Clarivate WoS 2024 / 2025 Data
IMPAQ
WoS SCIE Q2Scopus Q1SCImago #2,934Hybrid

Drugs & Aging

Acronym:draa
•
Abbreviation (ISO):DRUG AGING
•
Identifier (ISSN):1170-229X(Print)/1179-1969(Online)
•
Publisher:Springer International Publishing
Clarivate IF (2026)
4.2↑ +0.4
Journal Impact Factor
IF Trend↓
WoS Quartile
Q2
WoS SCIEJCR Quartile
Clarivate WoS JCR
WoS Categories↓
JCR Release Date: 2026-06-17

Impact Factor Trend (2018–2026)

Clarivate IF trend for Drugs & Aging

WoS Q2
13462.3820182.8520192.8220203.9220214.2720222.820233.420243.820254.22026
Annual Impact Factor Metric
Current (2026):4.2
Scopus SJR & RankScopus Q1
1.354
#2,934

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025
H-Index (2025)
119

119 papers with at least that number of citations each

WoS: SCIE / JCRQ2
Self-Citation Rate5.9%
Safe Level (< 15%)Warning Level (> 20%)
Self-citation below 15% indicates strong scholarly independence.
Volume & Open AccessHybrid
79articles/year
41.31% Gold OA•65.28% Original Research

Aims & Scope

Drugs & Aging delivers essential information on the most important aspects of drug therapy to professionals involved in the care of the elderly. The journal addresses in a timely way the major issues relating to drug therapy in older adults including: the management of specific diseases, particularly those associated with aging, age-related physiological changes impacting drug therapy, drug utilization and prescribing in the elderly, polypharmacy and drug interactions.

Topics Covered (Recognized by AI)
Medicine99.8%Internal medicine96.4%Biology91.1%Psychology73.3%Pathology69.6%Psychiatry68.1%Pharmacology56%Nursing48.2%Chemistry43%Intensive care medicine42.6%Surgery40.8%Biochemistry38%Pharmacotherapy36%Genetics35%Endocrinology34.6%Disease29.4%Sociology26%Mathematics24.8%Environmental health24.5%Demography24%Adverse effect24%Population23.2%Statistics20.4%
Primary Research Areas

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI
JCRSCIE2026

GERIATRICS & GERONTOLOGY

Q2
Rank27/72
IndexSCIE
JCRSCIE2026

PHARMACOLOGY & PHARMACY

Q2
Rank102/356
IndexSCIE
JCISCIE2026

GERIATRICS & GERONTOLOGY

Q2
Rank33/73
IndexSCIE
JCISCIE2026

PHARMACOLOGY & PHARMACY

Q2
Rank113/356
IndexSCIE

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year
2026Latest
IF4.2
Articles / Year60
Total Citations43
2025
IF3.8
Articles / Year104
Total Citations393
2024
IF3.4
Articles / Year79
Total Citations720
2023
IF2.8
Articles / Year94
Total Citations1,291
2022
IF4.271
Articles / Year79
Total Citations1,677

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #2,934Scopus Q1SCImago Profile
Scopus Coverage:1991-2026
Scopus Broad Areas:Medicine
Scopus Citation Rank (SJR)Q1
1.354

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q1
Citations / Doc (2 years)
4.50

Average citations received per document published in the 2-year window.

2-Year Citation Window
Estimated Publication Fee (APC)
$3,378 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations1,166
3-Year Documents244
Citable Documents240

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate47.1%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

Geriatrics and GerontologyQ1
Pharmacology (medical)Q1
Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth
Self-citation: 5.9%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):
2区 (Zone 2)Medicine
Minor Category (Specific Field):
3区GERIATRICS & GERONTOLOGY
CAS Early Warning List History:
Updated annually: 2020 – 2024
2020
Not warned
2021
Not warned
2022
Not warned
2023
Not warned
2024
Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Drugs & Aging (acronym: draa, abbr: DRUG AGING, ISSN: 1170-229X) is a peer-reviewed international scholarly journal in the field of Medicine, published by Springer International Publishing in New Zealand since 1991. The periodical holds a Journal Impact Factor (JIF) of 4.20, ranking in quartile Q2 of Web of Science (SCIE), a Scopus SJR indicator of 1.354 (Q1), an H-index of 119.

The journal enforces rigorous peer evaluation with a publication frequency of Monthly, an annual output of approximately 79 scientific articles. In terms of accessibility and author fees, it operates under the Hybrid model with an estimated APC of $3,378 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.

Publishing & Editorial Information

Detailed publisher, peer-review turnaround, and publication cycle specifications

Open Access Model
Hybrid
Publisher
Springer International Publishing
Publication Language
English
Frequency
Monthly
Founding Year
1991
Indexing & Databases
SCIEScopusPubMed
Editorial Address
ADIS INT LTD, 41 CENTORIAN DR, PRIVATE BAG 65901, MAIRANGI BAY, AUCKLAND, NEW ZEALAND, 1311

Similar Journals in Discipline

Journals in the same research field with comparable impact metrics

Record UUID: 7b691125-6a7b-4d3b-bfd4-f988e1d9edb4
Database Updated: 2026-09-28